In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line
- 1. Univ. Hospital, Lund (Sweden). Dept. of Oncology
Description
The current study was designed to compare the radiosensitizing effects of oxaliplatin and 5-fluorouracil (5FU) in a human colon cancer cell line. A human colon cancer cell line (S1) was treated with various doses of oxaliplatin, 5FU, radiation, and combinations thereof. Various clinically used schedules were mimicked. 5FU was either incubated during 1 h ('bolus') or 24 h ('continuous infusion'). When combining oxaliplatin and 5FU, an isobologram analysis revealed synergistic effects, regardless of 5FU schedule. The IC10 and IC50-doses for the drugs where then combined with radiotherapy. With equitoxic drug doses (IC50), radiosensitization was observed in the following order: oxaliplatin>5FU 24 h>5FU 1 h exposure. The degree of potentiation corresponded to approximately 0.8 Gy, 0.7 Gy, and 0.2 Gy, respectively. In this experimental setting, oxaliplatin seemed to be a better radiosensitizer than 5FU, and longer incubation time with 5FU was better than short exposure
Availability note (English)
Available from DOI: http://dx.doi.org/10.1080/02841860500247552Additional details
Identifiers
Publishing Information
- Journal Title
- Acta Oncologica (Stockholm)
- Journal Volume
- 44
- Journal Issue
- 7
- Journal Page Range
- p. 687-693
- ISSN
- 0284-186X
INIS
- Country of Publication
- Sweden
- Country of Input or Organization
- Sweden
- INIS RN
- 36114965
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- DIGESTIVE SYSTEM DISEASES; FLUOROURACILS; LARGE INTESTINE; RADIOSENSITIZERS; RADIOTHERAPY
- Descriptors DEC
- ANTIMETABOLITES; AZINES; BODY; DIGESTIVE SYSTEM; DISEASES; DRUGS; GASTROINTESTINAL TRACT; HETEROCYCLIC COMPOUNDS; HYDROXY COMPOUNDS; INTESTINES; MEDICINE; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANIC FLUORINE COMPOUNDS; ORGANIC HALOGEN COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PYRIMIDINES; RADIOLOGY; RESPONSE MODIFYING FACTORS; THERAPY; URACILS